Finance
Barclays raises Oruka Therapeutics price target to $160 on drug data
Barclays raises Oruka Therapeutics price target to $160 on drug data
I
Investing.com
April 27, 2026·1 min read
GM
FinanceBarclays raises Oruka Therapeutics price target to $160 on drug data
Original article
Barclays raises Oruka Therapeutics price target to $160 on drug data
Published by Investing.com